Furthermore, the results of Hoechst staining and FCM assays demonstrated that niclosamide induced apoptotic death in breast cancer cells in a concentration-dependent manner, which was further confirmed by the down-regulation of Bcl-2 and the up-regulation of cleaved caspase-3. This evidence concerns the gene BCL2 and breast carcinoma.